Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Outside the Lab Microbiology and immunology, Clinical care

The Castleman Criteria

A novel ruleset may give hope to iMCD patients who remain undiagnosed

William Aryitey |

When your symptoms belong to a rare illness, such as Castleman disease (a lymph node disorder), the diagnostic outlook is bleak. Idiopathic multicentric Castleman disease (iMCD) is a life-threatening subtype that affects multiple lymph nodes. With no established diagnostic protocol in place, sufferers may remain undiagnosed – or misdiagnosed with lymphoma or autoimmune disorders – for years. To offer a solution, a multinational team of investigators banded together to pioneer a set of identification criteria (1).

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Forgot your password?

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Outside the Lab Microbiology and immunology, Clinical care

About the Author

William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

Related Webinars

Outside the Lab Point of care testing

A Question of Quality

| Sponsored by Royal College of Pathologists

Outside the Lab Screening and monitoring

Determining tumour mutation burden using Oncomine Tumour Mutation Load Assay

| Sponsored by Thermo Fisher Scientific

Outside the Lab Oncology

Implementing the 2017 WHO Cancer Resolution: Time to acknowledge the critical role of pathology & laboratory medicine services?

Related Articles

Diagnostics Histology

Case of the Month

Subspecialties Microbiology and immunology

Rapid Action Against MRSA

| Michael Schubert

Diagnostics Microbiology and immunology

Combating Coronavirus Through Gene Sequencing

| Michael Schubert

Most Popular

1. Inside the Lab Laboratory management

Consolidation Lessons Learned

| Simon Brewer

2. Inside the Lab Genetics and epigenetics

The Diagnostic Power of DNA Methylation

| Bekim Sadikovic

3. Subspecialties Training and education

Bad Grades for Gleason

| Jonathan Epstein

4. Outside the Lab Profession

So You Want to Be a Pathologist…

| Nadeem Zafar and Jennifer Baccon

5. Outside the Lab Regulation and standards

The Formalin Ban: From Lethal Threat to Unique Opportunity

| Aurelio Ariza

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register

February Issue of The Pathologist